Table 1.
Characteristics of participants enrolled in this study.
| Overall (n = 149)a | COVID-19 (n = 67) | Non-COVID 19 (n = 82) | p-value | |
|---|---|---|---|---|
| Age (years), median (IQR) | 40 (33−48.5) | 40 (35−50) | 39.5 (33−48.3) | 0.588 |
| Male, n. (%) | 46 (30.9) | 23 (34.32) | 23 (28.04) | 0.470 |
| Onset of symptoms before the test (days), median (IQR) | 4 (3−6) | 4 (3−6) | 4.5 (3−6) | 0.548 |
| Symptoms at sample collection | ||||
| Headache, n (%) | 82 (61.2) | 33 (53.2) | 49 (68.1) | 0.109 |
| Cough, n (%) | 60 (45.1) | 30 (49.2) | 30 (41.7) | 0.484 |
| Myalgia, n (%) | 54 (40.3) | 25 (40.3) | 29 (40.3) | 1 |
| Sore throat, n (%) | 50 (37.3) | 14 (22.6) | 36 (50) | 0.001 |
| Fever, n (%) | 37 (27.6) | 25 (40.3) | 12 (16.7) | 0.003 |
| Anosmia, n (%) | 29 (21.6) | 20 (32.3) | 9 (12.5) | 0.007 |
| Ageusia, n (%) | 28 (20.9) | 18 (29.0) | 10 (13.9) | 0.035 |
| Chills, n (%) | 27 (17.9) | 10 (16.1) | 14 (19.4) | 0.658 |
| Chest pain, n (%) | 18 (13.4) | 9 (14.5) | 9 (12.5) | 0.802 |
| Dyspnea, n (%) | 16 (11.9) | 9 (14.5) | 7 (9.7) | 0.433 |
a
Concordant results for SARS-CoV-2 by RT-PCR between swab and saliva samples.